Multicenter validation of plasma p-tau217/ amyloid beta 1-42 ratio in symptomatic Alzheimer’s disease.

Moghekar AR, Rock JA, Mohs RC, Hansson O, Stomrud E, Palmqvist S, Mattsson-Carlgren N, Johnson SC, Zetterberg H, Radwan RR, Junfola J, Miller MC, Buitrago L, De Simone FI, Martin K, Dickson D, Benina N, Hawkins DM.